Scholars Central

Conference abstractPublished 2018

TRPV4-TAZ signaling in matrix stiffness and TGFβ1-induced epithelial-mesenchymal transition

Authors: Shaik O Rahaman

University of Maryland, USA

Abstract

Epithelial-mesenchymal transition (EMT) is an essential event in development, fibrogenesis, and oncogenesis. Emerging data support a role for both a mechanical signal, and a biochemical signal, in EMT. Here, we report evidence that transient receptor potential vanilloid 4 (TRPV4), a channel sensitive to both matrix stiffness and transforming growth factor β1 (TGFβ1) stimuli, is a likely mediator of EMT. We found that antagonism of TRPV4 blocked both matrix stiffness- and TGFβ1-induced EMT in normal human primary epidermal keratinocytes, as determined by changes in morphology and alterations in expression of EMT markers including E-cadherin, N-cadherin, and α-smooth muscle actin (α- SMA). In a murine dermal fibrosis model, TRPV4 deletion resulted in decreased expression of the mesenchymal marker, α-SMA, and increased expression of epithelial marker, E-cadherin. Furthermore, we found that: i) TRPV4 was essential for the nuclear translocation of TAZ in response to matrix stiffness and TGFβ1; ii) Antagonism of TRPV4 inhibited both matrix stiffness-induced and TGFβ1- induced expression of TAZ proteins; and iii) TRPV4 antagonism suppressed both matrix stiffness-induced and TGFβ1-induced activation of Smad2/3, but not of AKT. Altogether, these data identify a novel role for TRPV4 in regulating EMT in response to both matrix stiffness and TGFβ1.

Subjects

Engineering

More from this journal

The newest in Journal of Regenerative Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Regenerative Medicine
  • SubjectEngineering
  • BylineArticles whose byline prints “Shaik O Rahaman”